To insource or outsource drug commercialisation? Flexibility is the answer
Pharmaceutical Technology
SEPTEMBER 2, 2022
Yet despite this promising data, it’s a well-known fact that drug launches are under-performing – with around two-thirds of new drugs successfully navigating the long and rocky approval process only to fall drastically short of their pre-launch sales expectations. De-risking drug launch.
Let's personalize your content